The active ingredients act by altering the structure of the adipocyte and reducing the volume of the SFA

Dermaheal LL is a lip care product consisting of 3 active ingredients including a complex of biomimetic peptides, Phosphatidylcholine and L-carnitine.

Promotes changes in the structure of the adipocyte and reduces the volume of the VFA. It is indicated for the lip care of stretched skin. Provides face lifting by reducing adipose tissue.

3 ACTIVE INGREDIENTS

The effectiveness of the drug is due to its composition, which includes 3 active ingredients

BIOMIMETIC PEPTIDE

Decapeptide -4 (C9-IDP2): Promotes muscle metabolism.

HYDROLYZED LECITHIN

Hydrolyzed Lecithin (Phosphatidylcholine): The main phospholipid in our cell membranes. Phosphatidylcholine (phospholipid) is a component of bile and is responsible for the emulsification of lipids. Phosphatidylcholine is widely used in the prevention and treatment of fatty embolism. In addition, there was a decrease in systemic cholesterol and triglyceride levels.

CARNITIN

Carnitine (L-Carnitine): Reduces the presence of fatty acids in adipocytes and glycerol released during lipolytic processes.

PURPOSE AND APPLICATION

Dermaheal LL is indicated for the liporeduction of stretched skin. The product is injected using a mesoroller. The specific application is described below.

Methods: mesoroller

Processing techniques: Consecutive passes with a mesoroller in different directions and application of the treated area with Dermaheal LL.

Treatment area: Chin, neck, oval face, body (area with local fatty deposits).

Before starting treatment, patients should be interviewed according to their medical records and informed about the expected result of treatment and potential unwanted effects. The area to be treated must be appropriately disinfected.

INDICATIONS

• Excess skin

• Cellulite

• To reduce the volume of local subcutaneous fatty tissue

• Sequential treatment is required to achieve the expected effect

Administration methods

• 1st Phase 1 session every week for the first month

• 2nd Phase 1 session every 2 weeks during the second month

• 3rd Phase 1 session per month for the third month

• 4th Phase 1 session every 2 ~ 3 months for 6 months

Intensive application course

• 1st Phase 2 sessions every week for the first month

• 2nd Phase 1 session every week for the second month

• 3rd Phase 1 session every 2 weeks during the third month

• 4th Phase 1 session every 1 ~ 2 months for 6 months

Determining the most appropriate treatment depends on your skin condition.

Depending on the thickness of the fat fold, an appropriate needle is selected for mesoliposuction (the solution is injected DEEP throughout the entire thickness of the fat fold into the subcutaneous fat):

30Gx13mm needles - 13mm needle length for mild to moderate fat fold

Needles 27Gx25 mm - needle length 25 mm for pronounced fat fold

SHELF LIFE AND STORAGE

Expiration date: 2 years from the date of production

Shelf life after opening: within 5 days in the refrigerator.

Storage: Store at 2˚C ~ 25˚C. Avoid exposure to sunlight.